ZX PACKING(603091)
Search documents
9月1日重要公告一览
Xi Niu Cai Jing· 2025-09-01 10:19
Group 1 - Weisheng Information won four projects in August with a total amount of 85.5377 million yuan, accounting for 3.12% of the company's total revenue for 2024 [1] - Longqi Technology's shareholder plans to reduce its stake by up to 4.09%, equating to a maximum of 19.1916 million shares [1] - Guojin Modern's subsidiary received a drug registration certificate for injectable Nicardipine, used for treating unstable angina [3][4] Group 2 - SAIC Motor reported a total vehicle sales of 363,400 units in August, a year-on-year increase of 41.04%, with new energy vehicle sales reaching 129,800 units, up 49.89% [5] - Kuka Home plans to invest 1.124 billion yuan to build a self-owned base in Indonesia, aiming to enhance its international strategy [6] - Samsung Medical's subsidiary signed a contract for an intelligent meter project in Egypt worth 58.8 million USD, approximately 419 million yuan [8] Group 3 - North Vehicle Blue Valley's subsidiary reported a total production of 10,587 units in August, a year-on-year decrease of 15.13%, while sales increased by 3.47% [12] - Xianghe Industrial signed contracts worth 400 million yuan for railway fastener system components [13] - Hengrui Medicine's HRS9531 injection has received acceptance for its marketing authorization application [14] Group 4 - Hualu Hengsheng resumed normal production after completing maintenance on production facilities [16] - Shanghai Pharmaceuticals' hydrochloride verapamil injection passed the consistency evaluation for generic drugs [18] - Shanghai Construction received approval for debt financing tools with a registration period of two years [20] Group 5 - Kangli Elevator terminated the sale of its wholly-owned subsidiary due to the buyer's failure to obtain necessary approvals [21] - Times Wan Heng appointed Li Zhizhong as the new deputy general manager [22] - Hanma Technology reported a total truck sales of 1,051 units in August, a year-on-year increase of 58.05% [24] Group 6 - Wenzhou Hongfeng's subsidiary received a utility model patent certificate for a servo adjustment device [26] - Yibin Technology received a project designation from a domestic new energy vehicle company, with an estimated total sales of 243 million yuan over five years [28] - Star Ring Technology's H-share issuance application was accepted by the China Securities Regulatory Commission [30] Group 7 - Microchip Bio's vice president resigned for personal reasons [31] - Zhongxin Co. announced the resignation of a non-independent director due to personal reasons [32] - Changcheng Military Industry's vice chairman resigned due to retirement [35] Group 8 - Jiukang Bio received four invention patent certificates related to detection reagents [36] - Meino Bio's subsidiary changed its registered address [37] - Kuangda Technology announced a potential change in control due to a share transfer [38] Group 9 - China Rare Earth confirmed no undisclosed significant matters amid stock price fluctuations [72]
众鑫股份(603091) - 关于公司非独立董事辞职的公告
2025-09-01 08:15
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 证券代码:603091 证券简称:众鑫股份 公告编号:2025-053 浙江众鑫环保科技集团股份有限公司 关于公司非独立董事辞职的公告 (一) 提前离任的基本情况 姓名 离任 职务 离任时间 原定任期 到期日 离任 原因 是否继续在上 市公司及其控 股子公司任职 具体职务 (如适用) 是否存在未 履行完毕的 公开承诺 宋锐 董事 2025 年 8 月 30 日 2027 年 12 月 1 日 个人 原因 否 不适用 是 浙江众鑫环保科技集团股份有限公司(以下简称公司)董事会于2025年8月30 日收到非独立董事宋锐先生的书面辞职报告,宋锐先生因个人原因向公司董事会 提出辞去公司第二届董事会董事职务。 一、非独立董事离任情况 (二) 离任对公司的影响 宋锐先生的辞职未导致公司董事会成员人数低于法定最低人数,不影响公司 董事会的正常运作。根据《中华人民共和国公司法》以及《浙江众鑫环保科技集 团股份有限公司章程》《浙江众鑫环保科技集团股份有限公司董事、高级管理人 员离职 ...
信达证券给予众鑫股份买入评级:泰国盈利优异,静待拐点显现

Mei Ri Jing Ji Xin Wen· 2025-08-31 08:41
每经AI快讯,信达证券8月31日发布研报称,给予众鑫股份(603091.SH,最新价:63.93元)买入评 级。评级理由主要包括:1)泰国盈利表现优异,H2成长加速;2)国内短暂承压,静待拐点显现;3) 盈利短暂承压,费用管控优异。风险提示:海外产能提升不及预期,海外需求修复不及预期,汇率波动 超预期。 每经头条(nbdtoutiao)——个人消费贷贴息明日开闸!贷30万元最多可享贴息3000元,一文读懂→ 免责声明:本文内容与数据仅供参考,不构成投资建议,使用前请核实。据此操作,风险自担。 (记者 王晓波) ...
信达证券:给予众鑫股份买入评级

Zheng Quan Zhi Xing· 2025-08-31 08:29
Group 1 - The core viewpoint of the report is that despite short-term challenges, the company is expected to see a recovery in profitability, particularly with strong performance from its Thailand operations [2][3][4] - In H1 2025, the company reported revenue of 675 million yuan, a decrease of 4.6% year-on-year, and a net profit of 117 million yuan, down 14.8% year-on-year [2] - The company's Thailand base achieved revenue of 62 million yuan and profit of 14 million yuan in H1 2025, with a net profit margin of 23.2%, indicating superior pricing power compared to domestic operations [2][3] Group 2 - Domestic operations faced significant pressure, contributing 241 million yuan in revenue, a decline of 34.7%, and a profit of 22 million yuan, down 70.7% year-on-year [3] - The company maintained a gross margin of 28.5% and a net margin of 14.6% in Q2 2025, despite external challenges [3] - The company is projected to achieve net profits of 340 million yuan, 610 million yuan, and 780 million yuan for the years 2025, 2026, and 2027, respectively, with corresponding PE ratios of 19.5X, 10.8X, and 8.4X [4]
众鑫股份(603091):泰国盈利优异,静待拐点显现
Xinda Securities· 2025-08-31 08:25
Investment Rating - The investment rating for the company is "Buy" [1] Core Insights - The company reported a revenue of 675 million yuan for H1 2025, a decrease of 4.6% year-on-year, and a net profit of 117 million yuan, down 14.8% year-on-year [2] - The decline in revenue and profit is attributed to the impact of U.S. tariffs and anti-dumping measures, leading to a gradual shift of orders to Thailand, which is currently facing capacity constraints [2] - The Thai base showed strong performance with H1 revenue of 62 million yuan and a profit of 14 million yuan, reflecting a net profit margin of 23.2% [2] - The domestic base faced challenges with H1 revenue of 241 million yuan, down 34.7% year-on-year, and a profit of 22 million yuan, down 70.7% year-on-year [2] Financial Performance Summary - For Q2 2025, the company achieved a gross margin of 28.5%, a decrease of 7.9 percentage points year-on-year, and a net margin of 14.6%, down 5.3 percentage points year-on-year [3] - The company’s operating cash flow for Q2 2025 was 113 million yuan, an increase of 131 million yuan year-on-year [3] - The projected net profits for 2025-2027 are 336 million yuan, 606 million yuan, and 782 million yuan respectively, with corresponding P/E ratios of 19.5X, 10.8X, and 8.4X [3][5]
众鑫股份2025年中报简析:净利润同比下降14.76%
Zheng Quan Zhi Xing· 2025-08-29 22:42
Financial Performance - The company reported a total revenue of 675 million yuan for the first half of 2025, a decrease of 4.57% year-on-year [1] - The net profit attributable to shareholders was 116 million yuan, down 14.76% compared to the previous year [1] - The gross margin was 31.62%, reflecting a decline of 8.77% year-on-year, while the net margin decreased by 10.62% to 17.27% [1] - In Q2 2025, total revenue was 303 million yuan, a significant drop of 17.87% year-on-year, with net profit at approximately 44.31 million yuan, down 39.8% [1] Cost and Expenses - Total selling, administrative, and financial expenses amounted to 59.79 million yuan, representing an increase of 54.78% year-on-year, which accounted for 8.86% of total revenue [1] - The company’s interest-bearing debt rose by 22.69% to 426 million yuan [1] Shareholder Metrics - Earnings per share (EPS) decreased by 35.96% to 1.14 yuan, while the net asset value per share increased by 23.56% to 19.86 yuan [1] - Operating cash flow per share saw a significant increase of 197.58%, reaching 2.43 yuan [1] Business Model and Investment Returns - The company's return on invested capital (ROIC) for the previous year was 18.06%, with a historical median ROIC of 22.9% since its listing [3] - The company’s business performance is primarily driven by capital expenditures, necessitating careful evaluation of the profitability of these investments [3] Fund Holdings - Notable funds holding shares in the company include Guangfa Ruiyang and multiple funds from Everbright, indicating a growing interest in the stock [4] - Guangfa Ruiyang holds 450,000 shares, marking a new entry into the top ten holdings [4] Production Capacity - The company’s factory in Thailand has completed its first phase and is currently operating at full capacity, with stable product quality and reasonable cost control [5]
众鑫股份: 《累积投票实施细则》
Zheng Quan Zhi Xing· 2025-08-29 16:41
浙江众鑫环保科技集团股份有限公司 累积投票制实施细则 第一章 总则 第一条 为进一步完善浙江众鑫环保科技集团股份有限公司(以下简称"公司") 法人治理结构,规范公司董事的选举,切实保障公司所有股东充分行使权利,根 据《中华人民共和国公司法》等相关法律、行政法规和规范性文件以及《浙江众 鑫环保科技集团股份有限公司章程》(以下简称"《公司章程》")的规定,制定本 细则。 第二条 本细则所称累积投票制,是指股东会选举董事时,每一股份拥有与应 选董事总人数相同的表决权,股东拥有的表决权可以集中使用。 第三条 在股东会上拟选举或变更两名或两名以上的董事的,适用本实施细则。 第四条 在股东会上拟选举两名或两名以上的董事时,董事会在召开股东会通 知中,表明该次董事的选举采用累积投票制。 第五条 本实施细则所称董事特指非由职工代表担任的董事。由职工代表担任 的董事由公司工会或职代会或其他形式民主选举产生或更换,不适用于本实施细 则的相关规定。 第二章 董事的提名 第六条 在章程规定的人数范围内,按照拟选任的人数,由董事会提出董事 候选人名单。经董事会决议通过后,提交股东会选举;由董事会提出拟由股东代 表出任的董事候选人名单, ...
众鑫股份: 《信息披露管理制度》
Zheng Quan Zhi Xing· 2025-08-29 16:41
第三条 本制度所称"披露"是指在规定时间内、通过规定的媒体、按规定 的程序、以规定的方式向社会公众公布信息,并按规定报送有关证券监管机构。 第四条 本制度所称"及时"是指自起算日起或者触及披露时点的两个交易 日内。 浙江众鑫环保科技集团股份有限公司 信息披露管理制度 第一章 总 则 第一条 为了规范浙江众鑫环保科技集团股份有限公司(以下简称"公司") 的信息披露行为,加强信息披露事务管理,确保公司信息披露内容的真实、准确、 完整,保护投资者合法权益,根据《中华人民共和国公司法》(以下简称"《公 司法》")、《中华人民共和国证券法》(以下简称"《证券法》")和《上市 公司信息披露管理办法》(以下简称"《披露办法》")、《上海证券交易所股 票上市规则》(以下简称"《上市规则》")等有关法律、行政法规和规范性文 件及《浙江众鑫环保科技集团股份有限公司章程》(下称"公司章程")的规定制 定本制度。 第二条 本制度所称"信息"是指所有可能对公司证券及其衍生品种的交易 价格产生重大影响的信息,以及相关法律、法规、规章、规范性文件及证券监管 部门要求披露的其他信息。 第五条 本制度所称"信息披露义务人"是指上市公司及其董事 ...
众鑫股份: 《重大经营与投资决策管理制度》
Zheng Quan Zhi Xing· 2025-08-29 16:41
Core Points - The article outlines the major operational and investment decision-making management system of Zhejiang Zhongxin Environmental Protection Technology Group Co., Ltd, aiming to ensure scientific, standardized, and transparent decision-making processes while safeguarding the interests of the company and its shareholders [1][2]. Decision Scope - The decision-making matters include asset purchases or sales, external investments, financial assistance, guarantees, leasing assets, asset management, donations, debt restructuring, licensing agreements, R&D project transfers, rights waivers, financing activities, and other operational and investment matters [2]. Decision Authority and Procedures - Approval for operational investment matters must follow the stipulations of the Company Law and other relevant regulations. Certain thresholds require shareholder or board approval, such as transactions involving assets exceeding 50% of the company's total audited assets or net assets exceeding 50 million yuan [3][4][5]. - The general manager can approve contracts up to 40 million yuan, while contracts exceeding this amount require the chairman's consent [8]. Decision Execution and Supervision - The execution of investment decisions must align with the resolutions made by the shareholders' meeting and the board of directors. The responsible business department must create a feasible implementation plan, and the financial department must ensure proper funding allocation [11][12]. - Internal audits will be conducted to monitor the financial status of investment projects, and a public bidding process is mandated for fixed asset investments [11]. Miscellaneous - The management system will be effective upon approval by the shareholders' meeting, and the board of directors is authorized to interpret the system [13].
众鑫股份: 《募集资金管理制度》
Zheng Quan Zhi Xing· 2025-08-29 16:41
Core Viewpoint - The document outlines the fundraising management system of Zhejiang Zhongxin Environmental Protection Technology Group Co., Ltd, emphasizing the importance of regulating the use and management of raised funds to protect investors' interests [1]. Fundraising Management - The company must establish internal control systems for the storage, use, and management of raised funds, ensuring clear regulations on storage, usage, changes, supervision, and accountability [1][2]. - The board of directors and senior management are responsible for ensuring the proper use of raised funds and must not participate in any unauthorized changes to the fund's purpose [2][3]. Fund Storage - Raised funds must be stored in a special account approved by the board of directors, and this account should not be used for non-fund purposes [7]. - A tripartite supervision agreement must be signed with the sponsor and the commercial bank within one month of the funds being received, detailing the management and oversight of the funds [8][9]. Fund Usage - The company must adhere to specific requirements when using raised funds, including clear application procedures, decision-making processes, and risk control measures [9][10]. - Funds should primarily be used for the company's main business, and any financial investments or loans to related parties are prohibited [10][11]. Idle Funds Management - Idle funds can be temporarily used for cash management, provided that the investments are safe and do not affect the normal investment plans [11][12]. - If idle funds are used to supplement working capital, it must be reported and approved by the board, and the funds must be returned to the special account within a specified timeframe [12][13]. Use of Excess Funds - Any excess funds raised beyond the planned amount must be allocated to ongoing or new projects, or for share buybacks, with a clear plan disclosed by the company [13][14]. - The use of excess funds requires board approval and must be disclosed to shareholders, ensuring transparency and accountability [14]. Fund Usage Change - Any changes to the use of raised funds must be approved by the board and the shareholders, with a clear explanation provided for the changes [18][19]. - The company must conduct feasibility analyses for new projects and ensure that they align with the main business objectives [19][20]. Fund Management and Supervision - The company is required to disclose the actual use of raised funds accurately and completely [23]. - The board must conduct semi-annual reviews of the fundraising projects and report on the status of fund usage [24][25]. Compliance and Reporting - Independent directors and the audit committee must monitor the management and usage of raised funds, and can engage external auditors for verification [25][26]. - The sponsor must conduct regular investigations into the management of raised funds and provide reports to the company and the stock exchange [26][27].